A detailed history of Farther Finance Advisors, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 105 shares of LQDA stock, worth $1,156. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105
Previous 175 40.0%
Holding current value
$1,156
Previous $2.11 Million 50.17%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$8.9 - $14.11 $623 - $987
-70 Reduced 40.0%
105 $1.05 Million
Q2 2024

Jul 31, 2024

BUY
$11.96 - $15.71 $837 - $1,099
70 Added 66.67%
175 $2.11 Million
Q4 2023

Feb 14, 2024

BUY
$5.77 - $12.19 $605 - $1,279
105 New
105 $1.26 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.